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A genome-wide screen revealed previously unidenti-
fied components required for transport and Golgi
organization (TANGO). We now provide evidence
that one of these proteins, TANGO1, is an integral
membrane protein localized to endoplasmic retic-
ulum (ER) exit sites, with a luminal SH3 domain and
a cytoplasmic proline-rich domain (PRD). Knock-
down of TANGO1 inhibits export of bulky collagen
VII from the ER. The SH3 domain of TANGO1 binds
to collagen VII; the PRD binds to the COPII coat
subunits, Sec23/24. In this scenario, PRD binding
to Sec23/24 subunits could stall COPII carrier
biogenesis to permit the luminal domain of TANGO1
to guide SH3-bound cargo into a growing carrier. All
cells except those of hematopoietic origin express
TANGO1. We propose that TANGO1 exports other
cargoes in cells that do not secrete collagen VII.
However, TANGO1 does not enter the budding
carrier, which represents a unique mechanism to
load cargo into COPII carriers.
INTRODUCTION
Newly synthesized secretory proteins exit the endoplasmic retic-
ulum (ER) in so-called COPII-coated vesicles (Bonifacino and
Glick, 2004; Lee et al., 2004). A large number of proteins are
required for the biogenesis of these vesicles, including chaper-
ones and enzymes that fold the newly synthesized protein in
the lumen of the ER, receptors that bind secretory cargo and
help their recruitment into the newly forming carriers, structural
coat proteins that help mold the flat ER membrane into a bud
and promote its growth into a vesicular element, and compo-
nents that catalyze the budding of cargo-loaded carriers from
the ER (Herrmann et al., 1999; Lee et al., 2004).COPII coat-mediated budding of vesicles from the ER is rela-
tively well characterized. Two layers of coat proteins comprised
of a Sec23/24 inner layer and a Sec13/31 outer layer are
recruited to the membrane surface by Sar1-GTP at specific ER
exit sites that are marked by the protein Sec16 (Bonifacino and
Glick, 2004; Lee et al., 2004). Less is known about how cargo
proteins are collected into nascent vesicles. Whether it is
a passive process (bulk flow) or actively mediated by cargo
receptors has been debated extensively (Wieland et al., 1987;
Lee et al., 2004). Support in favor of the bulk flow proposal,
however, is waning by recent growing evidence that cargo
loading into COPII carriers utilizes receptors and chaperones
(Lee et al., 2004). The receptors identified thus far appear to
exit with the outgoing cargo, whereas the chaperones mostly
stay behind in the ER (Lee et al., 2004).
Prominent examples of cargo receptors are ERGIC 53 for the
transport of coagulation factors V and VIII, cathepsin C and Z,
and a1-antitrypsin; Erv29p/Surf4 for the export of soluble cargo
proteins such as precursor of a factor mating pheromone; and
Emp24p for GPI-anchored membrane protein Gas1p (Belden
and Barlowe, 2001; Muniz et al., 2000; Nichols et al., 1998; Nyf-
eler et al., 2008; Vollenweider et al., 1998). Additional relatives of
these three proteins have also been identified (Baines and
Zhang, 2007). Another well-characterized cargo receptor is the
KDEL receptor, which traffics KDEL-containing proteins from
the Golgi to the ER (Munro and Pelham, 1987; Pfeffer, 2007).
Chaperones primarily assist in the folding of newly synthesized
proteins and, therefore, are required for export from the ER. In
addition to the conventional chaperones, BAP31 and the
yeast-specific Shr3p also appear to function as cargo receptors
(Baines and Zhang, 2007; Kota et al., 2007). It has been esti-
mated that as many as 35% of the entire human genome enters
the secretory pathway at the ER. Considering the quantity and
the diversity of cargo exported by this compartment, the number
of receptors identified thus far seems surprisingly low.
We performed a genome-wide screen in Drosophila tissue
culture S2 cells to identify transport components (Bard et al.,
2006). This screen revealed a number of previously unidentified
genes required for transport and Golgi organization (TANGOCell 136, 891–902, March 6, 2009 ª2009 Elsevier Inc. 891
genes). TANGO1 from this collection emerges as a guide for
loading the cargo molecule collagen VII into COPII carriers.
Our findings provide further proof that collagen VII export from
the ER is not by bulk flow.
RESULTS
TANGO1 Localizes to ER Exit Sites
Drosophila TANGO1 contains an SH3-like domain at its
N terminus, followed by a potential transmembrane (TM) domain,
a coiled-coiled domain, and a C-terminal, proline-rich domain
(PRD). The mammalian ortholog of TANGO1 was identified by
sequence comparison, cloned, and HA-epitope tagged at its
C terminus. The domain organization of human TANGO1 is
basically the same asDrosophila TANGO1 except for two closely
situated potential transmembrane domains that were found in
the databases (amino acids 1143–1165 and 1183–1205)
(Figure 1A). A polyclonal antiserum was generated against the
PRD (C-terminal amino acids 1884–1898) of TANGO1 and
affinity purified. HA-tagged TANGO1 was expressed in COS7
cells and immunoprecipitated with anti-HA antibody and blotted
with either anti-HA or anti-TANGO1 antibodies. Both antibodies
recognized the exogenously expressed, tagged protein
(Figure 1B, lanes 1 and 2). TANGO1 migrates slower than the
expected molecular mass on SDS-PAGE. To detect the endog-
enous protein, HeLa cell extracts were either immunoprecipi-
tated with anti-TANGO1 antibody followed by western blotting
with anti-TANGO1 antibody (Figure 1B, lane 3), or cell extracts
from HeLa (Figure 1B, lane 4) and A431 (Figure 1B, lane 5)
were directly western blotted with anti-TANGO1 antibody. These
experiments revealed a major polypeptide of > 250 kDa, which
has the same mobility as the exogenously expressed, HA-
tagged TANGO1. This indicates that we have cloned the
mammalian TANGO1 and the antibody is suitable for further
characterization of this polypeptide. It has been reported that
the N-terminal 125 amino acid, which includes the SH3-like
domain of TANGO1, is secreted (Bosserhoff et al., 2004). This
portion has been given the name TANGO (the name is coinci-
dently the same as our transport and Golgi organization) and
MIA3 (melanoma inhibitory activity 3) (Bosserhoff et al., 2004).
The reported sequence contains a termination codon at the
376 base pair region of TANGO1 and is listed as US patent
WO 00/12762 (Bosserhoff et al., 2004); however, there are no
such sequences in the NCBI databases. Our RT-PCR also did
not reveal a termination codon at this site. Moreover, the data-
base search for other species, including Drosophila, zebrafish,
and mouse, did not reveal termination codons at the reported
site. The origin of TANGO, therefore, remains speculative, but
it is possible that, under certain conditions, a spliced variant of
TANGO1 is secreted. However, our results here describe the
full-length TANGO1 (1907 amino acids), which is localized to
the ER exit sites and is not secreted (see below).
The affinity-purified antiserum was used to visualize the
localization of endogenous TANGO1 protein in HeLa cells. The
antibody staining localized to punctate structures, 80% of which
colocalized with transfected Sec16L, a bona fide component of
ER exit sites (Figure 1C, panel 1). The antibody also displayed
a 60% colocalization with the endogenous ER exit site protein892 Cell 136, 891–902, March 6, 2009 ª2009 Elsevier Inc.Sec31A (Figure 1C, panel 2). ERGIC-53 of the intermediate
compartment (or ERGIC) appears as a collection of perinuclear
elements and punctate elements that are distributed throughout
the cytoplasm. There was only partial colocalization (30%)
between TANGO1 and the dispersed (peripheral) ERGIC-53
(Figure 1C, panel 3). No colocalization was observed between
TANGO1 and the perinuclear ERGIC-53 and between TANGO1
and b-COP (Figure 1C, panels 3 and 4). Thus, TANGO1 is local-
ized to the majority of ER exit sites.
HeLa cells were transfected with control or TANGO1-specific
siRNA. Immunofluorescence microscopy and western blotting
with anti-TANGO1 antibody was used to determine the depletion
of endogenous TANGO1. Immunofluorescence microscopy
revealed the loss of TANGO1 staining from the ER exit sites
(Figure S1A available online). Western blotting revealed > 90%
reduction in TANGO1 protein levels (Figure S1B). Thus, TANGO1
localizes to the ER exit sites, the anti-TANGO1 antibody is
suitable for analysis of the endogenous protein, and the siRNA
efficiently depletes TANGO1 in mammalian cells.
The Topology of TANGO1 at ER Exit Sites
To determine the topology of TANGO1, we made use of the fact
that digitonin can be used to selectively permeabilize the plasma
membrane, and, after paraformaldehyde (PFA) fixation, treat-
ment of the same cells with Triton X-100 permeabilizes both
plasma membrane and intracellular membranes. The cytoplas-
mically oriented region of the protein should be visible by fluores-
cence microscopy in cells treated with digitonin, whereas
detection of the luminal domain of a membrane protein should
require treatment with Triton X-100. As shown in Figure 2A, an
antibody that recognizes the luminal domain of ERGIC-53
required Triton permeabilization for binding to its cognate
epitope. In contrast, GM130, which is peripherally attached to
the cytoplasmic surface of cis-Golgi cisternae, was visible by
immunofluorescence microscopy in cells treated with digitonin
only (Figure 2A).
The anti-TANGO1 C-terminal-specific antibody was, there-
fore, used to reveal the orientation of this domain across the
ER. As shown in Figure 2A, digitonin treatment followed by fixa-
tion with PFA was sufficient to visualize endogenous TANGO1
protein with the C-terminal specific, anti-TANGO1 antibody.
This suggests that the C-terminal residues face the cytoplasmic
side. When TANGO1 is expressed exogenously in cells and fixed
with PFA, it yields amore diffused ER staining, but this should not
affect the topology of the protein. To determine the orientation of
the N-terminal SH3 domain, we generated a tagged version of
TANGO1 in which a FLAG tag was placed between the signal
sequence and the SH3 domain and an HA tag was introduced
at the C terminus of TANGO1 (FLAG-TANGO1-HA). The trans-
fected HeLa cells were treated with digitonin followed by fixation
and incubated with either anti-FLAG or HA antibodies (stage I).
The cells were then washed, treated with Triton X-100, and
incubated with anti-TANGO1 antibody (stage II). The transfected
cells were identified by higher TANGO1 staining compared with
the nontransfected cells. These cells were also visualized for the
staining with anti-FLAG or HA antibodies. Although HA antibody
gave a strong signal in these cells (Figure 2B, lane 2), the N-termi-
nally localized FLAG epitope was not detected in transfected
cells permeabilized with digitonin only (Figure 2B, lane 1). Treat-
ment of these cells with Triton revealed both the N terminus
FLAG and the C terminus HA tag as expected (Figure 2B, lanes
3 and 4). Thus, the transfected protein appears to show the
correct topology, and the FLAG epitope is not accessible to
the antibody in digitonin-permeabilized cells. This provides
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Figure 1. Cloning of Human TANGO1 and Its Locali-
zation
(A) Schematic representation of human TANGO1 domain
organization. ss, signal sequence. SH3, Src homology 3-like
domain. TM, putative transmembrane domain. CCD, coiled-
coiled domain. PRD, proline-rich domain.
(B) TANGO1-HA was immunoprecipitated from transfected
COS7 cells (lanes 1 and 2) and western blotted with anti-HA
(lane 1) and anti-TANGO1 (lane 2) antibody, respectively.
HeLa cell lysate was immunoprecipitated with anti-TANGO1
antibody and western blotted with anti-TANGO1 antibody
(lane 3). HeLa (lane 4) and A431 (lane 5) cell lysates were
western blotted with anti-TANGO1 antibody.
(C) Sec16L-GFP-transfected HeLa cells were stained with
TANGO1 antibody. Potential colocalization of TANGO1 with
Sec31A, ERGIC-53, and b-COP was tested with specific anti-
bodies in HeLa cells. Images were deconvolved with Auto-
quant. Scale bar, 10 mm.
strong evidence that the SH3 domain is localized
in the lumen of the ER.
As an additional and more quantitative approach
to determine the orientation of TANGO1 in the ER,
we tested the susceptibility of FLAG-TANGO1-HA
to partial proteolysis with trypsin. FLAG-TANGO1-
HA was expressed in COS7 cells; the cells were
permeabilized with digitonin and then treated with
trypsin. Following trypsin inactivation, the cells
were lysed, and the lysates were immunoprecipi-
tated with anti-FLAG antibody and western blotted
with anti-FLAG antibody (Figure S2, top panel) or
immunoprecipitated with anti-HA antibody followed
by western blotting with anti-HA antibody
(Figure S2, bottom panel). Under these conditions,
the C-terminal HA tag was lost upon trypsinization.
The N-terminal FLAG tag was, however, protected
from proteolysis, and the corresponding TANGO1
protein was migrated with the mobility predicted
for the remaining N terminus up to the two putative
transmembrane domains of TANGO1 (Figure S2,
top panel, lanes 4 and 6). Extraction with low
concentration (0.05%) of Triton X-100 followed by
trypsin treatment digested the protein, which was
not recognized by both anti-FLAG and anti-HA
antibodies (Figure S2, lane 5).
SOSUI and PHDhtm, programs that predict
potential TM domains, suggest two such domains
at amino acids 1143–1165 and 1183–1205, respec-
tively, in TANGO1. This is intriguing because the
results described above (Figures 2A, 2B, S2)
suggest that the N-terminal half of TANGO1 is in
the lumen and the C-terminal half is in the cyto-
plasm. To achieve this topology, however, there should be either
one or three TM domains. To test this experimentally, we gener-
ated recombinant TANGO1-HA (HA tag is at the C terminus)
lacking the first (DTM1), second (DTM2), or both potential TM
domains (DTM1+2). The respective constructs were expressed
in HeLa cells. Cells were treated with digitonin, fixed, and stainedCell 136, 891–902, March 6, 2009 ª2009 Elsevier Inc. 893
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Figure 2. The Topology of TANGO1
(A) (Upper panel) HeLa cells were permeabilized with digitonin, fixed with PFA, and stained with anti-ERGIC-53, anti-GM130, and anti-TANGO1 antibodies.
(Lower panel) HeLa cells were fixed with PFA and treated with Triton X-100. The cells were stained with antibodies to ERGIC-53, GM130, and TANGO1. Scale
bar, 10 mm.
(B) FLAG-TANGO1-HA was expressed in HeLa cells. The cells were permeabilized with digitonin, fixed with PFA, and incubated with either anti-FLAG (lane 1) or
anti-HA (lane 2) antibodies (stage I). The cells were treated with Triton X-100 followed by incubation with anti-TANGO1 (lanes 1 and 2) antibody (stage II). The cells
were processed and incubated with secondary antibodies. HeLa cells expressing FLAG-TANGO1-HA were fixed and permeabilized with Triton X-100 and
incubated with anti-TANGO1 antibody and either anti-FLAG (lane 3) or anti-HA (lane 4) antibodies, respectively. Scale bar, 10mm.
(C) HA-tagged full-lengthDTM1,DTM2, andDTM1+TM2were expressed in HeLa cells. The cells were permeabilizedwith digitonin, fixedwith PFA, and incubated
with anti-HA antibodies. The cells were washed and then treated with Triton X-100 and processed for immunofluorescence microscopy with anti-TANGO1 anti-
body. Scale bar, 10 mm.
(D) Two possible models of the TM domains in TANGO1. In the first, amino acids 1143–1165 span the ER membranes, whereas amino acids 1183–1205 are
partially embedded in the outer leaflet. In the second, amino acids 1143–1165 are partially embedded in the luminal leaflet, whereas amino acids 1183–1205
span the ER membranes.with HA antibody. The cells were then treated with Triton X-100
and stained with TANGO1 antibody. We hypothesized that dele-
tion of all TM domains would cause the polypeptide to be entirely
luminal and, therefore, not bound to the C-terminal-specific anti-
HA antibody in cells treated with digitonin only. Anti-TANGO1
antibody will recognize both the endogenous and exogenous
TANGO1, but the cells expressing the exogenous protein will
reveal higher (brighter) staining. As shown in Figure 2C, deletion
of either TM domain did not affect staining with the anti-HA anti-
body. However, deletion of both TM domains resulted in the loss894 Cell 136, 891–902, March 6, 2009 ª2009 Elsevier Inc.of staining. Based on these data, we suggest that one of the TM
domains spans the membrane, whereas the second must be
partially inserted into the inner or outer leaflet but does not cross
the ER membrane (Figure 2D).
TANGO1 Localizes to ER Exit Sites by Its PRD
Three different mutant forms of TANGO1 were generated and
expressed in HeLa cells. Construct DSH3 lacks the luminally
oriented SH3 domain, amino acids 48–106; construct DCT lacks
the C-terminal amino acids 1601–1907; and construct DCT2
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Figure 3. The PRD of TANGO1 Is Required for Its Localization at the ER Exit Sites
(A) HA-tagged full-length TANGO1, DSH3-TANGO-HA, DCT-TANGO-HA, and DCT2-TANGO-HA were expressed in HeLa cells. The cells were fixed with meth-
anol and incubated with anti-HA antibody to visualize the location of the expressed proteins. Loss of C-terminal region post coiled-coiled domain (DCT) and PRD
(DCT2) causes the expressed protein to relocate throughout the ER. Scale bar, 10 mm.
(B) CT, CT1, and CT2 domains of TANGO1 in pGADT7 plasmids were cotransformed with pGBKT7 plasmids containing Sec23A, Sec24C, or Sec31A into AH109
yeast strains and plated on tryptophan- and leucine-deficient medium. Cotransformed cells were replated on tryptophan-, leucine-, histidine-, and adenine-
deficient medium. Cell growth was observed in CT and CT2 cotransformed with Sec23A (marked with the numbers 6 and 8) and Sec24C (numbers 10 and
12), respectively.lacks amino acids 1751–1907. All constructs that contained a
C-terminal HA tag were visualized with anti-HA antibody.
Construct DSH3 localized to the ER exit sites similarly to the
full-length protein (Figure 3A, upper panel). Constructs DCT
and DCT2, lacking the PRD, were found dispersed in the ER
(Figure 3A, lower panel). This suggests that the PRD is required
for the localization of TANGO1 to the ER exit sites.
COPII component Sec31 contains a PRD that binds to Sec23/
Sec24 (Bi et al., 2007; Fromme et al., 2007; Shaywitz et al., 1997;
Shugrue et al., 1999). We tested by yeast two-hybrid whether the
TANGO1 PRD also interacts with Sec23/Sec24. The PRD in
TANGO1 stretches from amino acids 1751–1907. Figure 4B
shows three constructs of TANGO1 used to investigate the
importance of the PRD: CT (amino acids 1601–1907), CT1
(1601–1750), and CT2 (1751–1907) were used in yeast two-
hybrid for interaction with COPII components Sec23A,
Sec24C, and Sec31A. Only the PRD containing constructs CT
and CT2 were found to interact with both Sec23A and Sec24C
(Figure 3B). There was no interaction detected between the CT
domains and Sec31A (Figure 3B). These results indicate that
the C-terminal PRD of TANGO1 can bind to Sec23 and Sec24.
Given that this domain is required for ER exit site localization, itseems reasonable to conclude that TANGO1 is localized to ER
exit sites by interaction with Sec23/Sec24.
The SH3 Domain of TANGO1 Is Required
for Collagen VII Binding
TANGO1was selected in a screen for genes involved in secretion
of the soluble protein ss-horseradish peroxidase (HRP) in
Drosophila tissue culture S2 cells (Bard et al., 2006). HeLa cells
were transfected with control or TANGO1 siRNA followed by
transfection with ss-HRP. Knockdown of TANGO1 inhibited
HRP secretion by about 50% (Figure S3). However, TANGO1
depletion by siRNA in HeLa cells did not affect the trafficking
of another secreted protein, alkaline phosphatase (Figure S3),
and the integral membrane protein, VSV-G (data not shown).
The effect of TANGO1 depletion on the secretion of exogenously
expressed, plant-specific protein HRP is, therefore, quite
surprising.
To further test the involvement of TANGO1 in protein secretion
and cellular physiology, we searched for TANGO1 binding
partners by mass spectrometric analysis of immunoprecipitated
endogenous TANGO1 from HeLa cell extracts. This procedure
revealed six specific peptides of human collagen VIICell 136, 891–902, March 6, 2009 ª2009 Elsevier Inc. 895
(Figure 4A). Since collagen VII is a secreted protein, it is likely to
bind to the luminal domain of TANGO1. To test this proposal, we
generated various domains of FLAG-tagged TANGO1. These
domains were expressed in COS7 cells and immunoisolated
with anti-FLAG antibody. Tissue culture medium containing
secreted collagen VII from RDEB/FB/C7 cells was collected
and incubated with beads containing immunoisolated FLAG-
TANGO1. The beads were washed and subjected to SDS-
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Figure 4. TANGO1 Binds to Collagen VII
(A) HeLa cell extracts were immunoprecipitated with anti-TANGO1 antibody,
and the bound polypeptides were elutedwith TANGO1peptide used for gener-
ating the antibody and then sequenced by mass spectrometry. Six peptides
corresponding to collagen VII were contained in the immunoprecipitant with
anti-TANGO1 antibody.
(B) The C-terminal 3X FLAG-tagged full-length (full), luminal (lumen),
cytoplasmic (cytoplasm), and full-length lacking SH3 domain (DSH3) were
expressed in COS7 cells (top panel). The respective proteins were immunopre-
cipitated with anti-FLAG agarose beads and incubated with culture medium
from RDEB/FB/C7 cells containing secreted collagen VII. The beads were
washed and analyzed by SDS-PAGE followed by western blotting with anti-
collagen VII antibody (middle panel) and anti-FLAG antibody (lower panel).896 Cell 136, 891–902, March 6, 2009 ª2009 Elsevier Inc.PAGE followed by western blotting with anti-collagen VII anti-
body. The results show that full-length FLAG-TANGO1 (full)
and the luminal domain of TANGO1 (lumen) bind to collagen
VII (Figure 4B). TANGO1 lacking the luminal domain (cytoplasm)
or the SH3 domain (DSH3) does not bind to collagen VII
(Figure 4B). The same results were obtained when recombinant
proteins were used as a source for collagen VII (data not shown).
These findings strongly indicate the significance of the luminal
SH3 domain of TANGO1 for binding to collagen VII.
TANGO1 Is Required for Collagen VII Secretion
Collagen VII is expressed in skin keratinocytes and fibroblasts.
Therefore, we tested these cell types for the significance of
TANGO1 in collagen VII secretion. We first tested A431 (human
keratinocyte-like) cells for a role of TANGO1 in collagen VII
secretion. Although these cells synthesize and secrete collagen
VII, it is essentially impossible to detect an intracellular pool of
collagen VII by immunofluorescence microscopy under steady-
state conditions. However, about 50% of the cells revealed
accumulation of collagen VII in the ER upon depletion of
TANGO1 by siRNA (Figure 5A). This suggests that, without
TANGO1, synthesized collagen VII fails to exit the ER. Collagen
VII, consequently, accumulates in the ER and is, therefore,
detected by immunofluorescence microscopy.
To rule out the possibility that TANGO1 transcriptionally regu-
lates collagen VII synthesis, we tested human 293/C7 cells stably
expressing collagen VII under cytomegalovirus (CMV) promoter
for the involvement of TANGO1 in its export. The 293/C7 cells
were transfected with control or TANGO1 siRNA. Culture
medium from the cells was western blotted with anti-collagen
VII antibody. The results revealed that the quantity of collagen
VII secreted from TANGO1-depleted cells was about 80% less
compared with control cells (Figure 5B). There was a concomi-
tant, 3-fold increase in the intracellular pool of collagen VII in cells
depleted of TANGO1 (Figure 5B). We then tested the involve-
ment of TANGO1 in collagen VII secretion from RDEB/FB/C7
human skin fibroblast cells. These fibroblasts stably express
and secrete collagen VII and also secrete a detectable amount
of endogenous collagen I. Depletion of TANGO1 revealed >
70% inhibition in collagen VII secretion without any appreciable
effect on collagen I secretion (Figure 5C). To further ascertain the
involvement of TANGO1 in collagen I secretion, we transfected
human fibroblast cell line Saos2, which synthesizes and secretes
collagen I, with control or TANGO1 siRNA. These cells do not
secrete collagen VII. TANGO1 was efficiently depleted from
these cells (> 90% knockdown), but there were no obvious
effects on the secretion of collagen I (Figure 5D).
Ascorbic acid, a cofactor for prolyl 4-hydroxylase, regulates
synthesis and folding of collagens to generate a trimeric collagen
in the ER (Pinnel et al., 1987). We tested the effect of ascorbic
acid on collagen VII secretion in RDEB/FB/C7 cells. Because
these cells express collagen VII under a CMV promoter, the
effects of ascorbic acid on the synthesis of collagen VII can be
excluded. The addition of 2 mg/ml ascorbic acid to the cells
caused about a 5-fold increase in collagen VII secretion
(Figure S4). RDEB/FB/C7 cells grown in the presence of ascorbic
acid were transfected with TANGO1 siRNA, and its effects on
collagen VII secretion were monitored by western blotting. The
secreted collagen was analyzed in the absence or presence of
dithiothreitol (DTT) to visualize trimeric (900 kDa) andmonomeric
(290 kDa) collagen VII. Our findings reveal that RDEB/FB/C7 cells
secrete trimeric collagen, which increases in the presence of as-
corbic acid, and that knockdown of TANGO1 inhibited secretion
of trimeric collagen VII by > 50%. Under the same conditions,
collagen I secretion was not affected (data not shown). These
results strongly indicate that TANGO1 is required for the secre-
tion of fully folded trimeric collagen VII (Figure S4).
To test whether TANGO1 is required for general protein export
from the ER, A431 cells were transfected with control or
TANGO1 siRNA. The cells were pulsed with [35S]-methionine
for 1 hr followed by a chase for 3 hr. The cells treated with Bre-
feldin A (BFA), an inhibitor of protein export, were also pulsed
and chased. The medium was collected at 0, 1, 2, and 3 hr of
chase and analyzed by SDS-PAGE on 6% and 12% gels (to
separate the high- and low-molecular weight polypeptides)
followed by autoradiography. Our findings reveal that TANGO1
knockdown does not affect the overall amount of protein
secreted by A431 cells (Figure 5E). BFA treatment of the control
cells, as expected, efficiently inhibited the amount of total protein
secretion from A431 cells (Figure 5E).
We also tested the effect of TANGO1 knockdown on the orga-
nization of ER and the ER exit sites. We observed an aggregation
of Sec16L and Sec24D upon TANGO1 knockdown in A431 cells
(Figure S5). Electron microscopy analysis revealed a 2-fold
increase in the average length of ER cisternae and a 2.5-fold
increase in the density of ER in TANGO1-depleted A431 cells
(Figure S6). HeLa cells, which synthesize and secrete less
collagen VII than do A431 cells, showed marginal effects on
the organization of Sec16L, Sec24D, and the overall ER organi-
zation (data not shown). Thus, the effects of TANGO1 in the
organization of ER exit sites and ER are likely indirect due to
the accumulation of collagen VII within the ER.
Taken together, our findings suggest that TANGO1 does not
have a role in global protein secretion; it appears to be specific
for secretion of trimeric collagen VII.
TANGO1 Does Not Exit the ER
TANGO1 binds to collagen VII in the lumen of the ER and COPII
components, Sec23/24 on the cytoplasmic side. These interac-
tions require SH3 and PRD of TANGO1, respectively. Is TANGO1
loaded into COPII carriers and exported from the ER? This is an
important issue as other cargo receptors such as ERGIC53,
Erv29p, and KDEL-R bind their specific cargoes and are
exported from the budding compartment. We used an in vitro
COPII budding assay to test the hypothesis of whether TANGO1
is exported in COPII carriers from the ER. Permeabilized HeLa
cells were incubated with rat liver cytosol, ATP-regenerating
system, and GTP for 1 hr at 30C, and the budded vesicles
were collected as described previously (Fromme et al., 2007;
Kim et al., 2007a, 2007b). As expected, the anterograde
cargoes, ERGIC53 and APP, were contained in these carriers
(Figure 6, lanes 5 and 7). Incubation with GTPgS instead of
GTP inhibited this reaction as described previously (Figure 6,
lane 9) (Fromme et al., 2007; Kim et al., 2007a, 2007b). COPII
carrier formation is also inhibited by incubation with the GTP-
restricted form of Sar1, Sar1H79G (Figure 6, lane 6), but notwith preinactivated Sar1H79G (Figure 6, lane 7). Interestingly,
like Ribophorin I, which is a resident protein of the ER, TANGO1
was excluded from the COPII carriers (Figure 6, lanes 5 and 7).
These results indicate that, although TANGO1 binds to the cargo
and COPII coats, it is not incorporated into COPII carriers at the
ER exit sites.
DISCUSSION
We have described here the role of TANGO1, a protein that loads
collagen VII into transport carriers without following the cargo
into the vesicle itself. Thus, the mechanism of TANGO1-medi-
ated cargo loading is distinct from other previously described
cargo receptors, and this makes it unique among the known
guides of protein secretion. Collagen VII is a bulky 900 kDa trimer
that is too big to fit into a generic COPII vesicle of 60–90 nm
diameter. Therefore, TANGO1 provides a means to begin to
address the mechanism regulating the size of transport carriers;
moreover, upon secretion, collagen VII interacts with other adhe-
sive proteins and helps in the attachment of epidermis to the
dermis (Chen et al., 2002). Patients with genetic defects in
collagen VII or with autoantibodies to collagen VII have a number
of severe skin disorders, which are collectively called dystrophic
epidermolysis bullosa (DEB) and epidermolysis bullosa acquisita
(EBA), respectively (Chen et al., 2002; Woodley et al., 2007).
TANGO1-mediated collagen VII export could reveal important
insights into the process of skin biogenesis.
Until recently, there was a strong bias toward the proposal that
cargo export from the ER is by bulk flow (Wieland et al., 1987).
However, the identification of proteins such as ERGIC53,
Erv29p/Surf4, and Emp24p has shifted the balance in support
of the proposal that cargo export from the ER is receptor medi-
ated. Identification of TANGO1 as a guide for secretory cargo
such as collagen VII provides further support to the latter
proposal.
TANGO1 Is Distinct from Other Guides for Cargo
Loading
There are at least 30 different kinds of vertebrate-specific colla-
gens and numerous collagen-like molecules that are required for
tissue assembly or maintenance (Kadler et al., 2007). The fact
that TANGO1 depletion inhibits secretion of trimeric (900 kDa)
collagen VII without affecting transport of collagen I indicates
that TANGO1 is an unlikely candidate for the general synthesis,
posttranslational modification, and enzymatic folding of colla-
gens. TANGO1, therefore, loads folded trimeric collagen VII
into the newly forming COPII transport carriers. During this
process, it remains anchored at ER exit sites. TANGO1 is, there-
fore, distinct from other membrane proteins involved in cargo
loading with respect to its choice of cargo and location during
protein export from the ER.
TANGO1 May Slow COPII Biogenesis until Collagen VII
Is Loaded
TANGO1 has a number of unique features that make it an attrac-
tive candidate for cargo loading. It contains an SH3-like domain
in the lumen of the ER and a PRD facing the cytoplasm. This
arrangement allows TANGO1 at the site of COPII carrierCell 136, 891–902, March 6, 2009 ª2009 Elsevier Inc. 897
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Figure 5. TANGO1 Is Required for Collagen VII Export from the ER
(A) A431 cells that synthesize and secrete endogenous collagen VII were transfected with control or TANGO1 siRNA. The cells were fixed and stained with anti-
collagen VII and anti-TANGO1 antibodies. Knockdown of TANGO1 caused accumulation of collagen VII in the ER in about 50% of cells. Scale bar, 10 mm.
(B) The 293/C7 cells stably expressing collagen VII were transfected with control or TANGO1 siRNA. (a) The medium was western blotted with anti-collagen VII
antibody. The lysates were western blotted with anti-collagen VII, TANGO1, and b-Actin antibodies. (b) An average of three different experiments revealed that
knockdown of TANGO1 caused an 80% reduction in collagen VII secretion and a 3-fold increase in the intracellular pool of collagen VII. Error bars represent
mean ± SD. *p < 0.05 compared with the control siRNA.
(C) A stable cell line RDEB/FB/C7 that synthesizes and secretes exogenously expressed collagen VII and endogenous collagen I was transfected with control
or TANGO1 siRNA. (a) The medium was western blotted with anti-collagen VII and collagen I antibodies, respectively. The lysates were western blotted with898 Cell 136, 891–902, March 6, 2009 ª2009 Elsevier Inc.
biogenesis to bind cargo by the luminal SH3 domain and COPII
components Sec23/24 through its cytoplasmic PRD. Interest-
ingly, both TANGO1 and Sec31 contain a PRD, which interacts
with Sec23/24 of COPII coats. The binding of TANGO1’s PRD
could affect recruitment of Sec13/31 to Sec23/24 and thus stall
the completion of COPII biogenesis. Accordingly, when the PRD
is bound to Sec23/24, the COPII carrier grows as the SH3-bound
collagen VII is guided from the luminal side. Once cargo has been
loaded, a change in the conformation of TANGO1 could induce
dissociation of the PRD from Sec23/24 and collagen VII from
the SH3 domain, which could trigger the separation of a cargo-
filled COPII carrier. TANGO1 has a single transmembrane
domain and an additional hydrophobic stretch, which we
suggest partially spans the membrane, as found in another ER
resident protein, Rtn4a (Voeltz et al., 2006). While the transmem-
brane domain anchors TANGO1 in the membrane, the partially
embedded hydrophobic domain might act as a pivot to move
the cytoplasmic domain (1000 amino acid), thus regulating
the dynamics of TANGO1 in a cargo-dependent manner (Fig-
ure 7). This arrangement allows TANGO1 to load cargo without
entering the newly forming transport carrier.
Is TANGO1 Specific for Collagen VII Export?
All human cells, except those of hematopoietic origin, express
TANGO1 mRNA (Bosserhoff et al., 2004). Collagen VII, however,
Figure 6. TANGO1 Is Not Loaded into COPII Carriers
Digitonin-permeabilized HeLa cells (donor membrane) were incubated with
ATP regenerating system (lanes 3 and 5–9), GTP (lanes 3 and 5–8), GTPgS
(**, lane 9), Sar1 H79G (lane 6), Sar1 H79G pretreated at 65C for 10 min
(*, lane 7), and rat liver cytosol (lanes 4–9). COPII vesicles were collected by
centrifugation and western blotted with anti-TANGO1, anti-amyloid precursor
protein (APP), anti-ribophorin I, and anti-ERGIC53 antibodies. (Lane 1) Input,
7.5% of the donor membrane.is secreted predominantly by epidermal keratinocytes and
dermal fibroblasts (Chen et al., 1994). Because TANGO1 is ex-
pressed only in cells that attach directly or indirectly by an extra
cellularmatrix (ECM), it is reasonable to propose that, in cells that
do not secrete collagen VII, TANGO1 exports different secretory
cargo, which might also be involved in cell-cell attachment. Yet,
why does TANGO1 depletion inhibit secretion of the exoge-
nously expressed plant protein HRP by about 50% (albeit not
as strongly as collagen VII) (Bard et al., 2006)? There is no
obvious sequence homology between HRP and collagen VII. It
is, therefore, difficult to imagine that TANGO1 recognizes
a common sequence between these two proteins. We hope
that identification of other cargoes exported by TANGO1 will
reveal whether the affects on HRP secretion are direct or
whether HRP has features that make it a weak binding partner
of TANGO1.
The Effect of TANGO1 Depletion on the ER
and ER Exit Sites
Knockdown of TANGO1 in A431 cells caused aggregation of
Sec16L and Sec24D, and the ER increased in length and density
(Figures S5 and S6). HeLa cells, which secrete less collagen VII
than do A431 cells, revealed very minor changes in the organiza-
tion of Sec16L, Sec24D, and the overall ER (data not shown). The
effects of TANGO1 knockdown on ER organization and exit sites
are most likely indirect due to accumulation of collagen VII. It has
recently been reported that knockdown of Sec13 also causes
aggregation of Sec24C and Sec16 in HeLa cells (Townley
et al., 2008). Interestingly, although transport of VSV-G protein
to the cell surface was largely unperturbed, export of procolla-
gen I from the ER was blocked under such conditions. The effect
on the organization of ER exit sites upon Sec13 knockdown, we
suggest, is indirect as well, due to the accumulation of procolla-
gen I in the ER. These findings, however, raise an important
issue. If clustering of ER exit sites does not affect general protein
secretion, why are they distributed throughout the ER?
In sum, TANGO1 employs a unique mechanism to load secre-
tory cargo into COPII carriers. Identification of other TANGO1-
like cargo guides and cargoes exported by TANGO1 will help
in understanding the mechanism of protein export from the ER,
which is diverse in quality and large in quantity.
EXPERIMENTAL PROCEDURES
Antibodies
TANGO1 polyclonal antibody was raised in rabbits by immunization with
keyhole limpet hemocyanin-conjugated peptide (C-SRDEPPPASQSTSQD)
corresponding to the C-terminal amino acids 1884–1898 of TANGO1. Theanti-TANGO1 and b-Actin antibodies. (b) Quantitation of three different experiments revealed > 70% decrease in collagen VII secretion. Collagen I secretion, on
the other hand, was not significantly affected by TANGO1 depletion. Error bars represent mean ± SD. *p < 0.01 compared with the control siRNA.
(D) Saos2 cells that synthesize and secrete endogenous collagen I were incubated with control or TANGO1 siRNA. (a) The mediumwas western blotted with anti-
collagen I antibody; the cell lysates were western blotted with anti-collagen I, TANGO1, and b-Actin antibodies, respectively. (b) Quantitation of three different
experiments revealed statistically no effects on collagen I secretion upon TANGO1 depletion compared with control cells. Error bars represent mean ± SD.
(E) A431 cells were transfected with control or TANGO1 siRNA. After 48 hr, the cells were labeled with [35S]-methionine for 1 hr. The cells were washed and then
cultured in standard medium containing unlabeled methionine. At 0, 1, 2, and 3 hr after the chase, the medium was analyzed by SDS-PAGE on 6% (top) and 12%
(bottom) gels followed by autoradiography. Brefeldin A (BFA) was added to one-half of the control cells for the last 10 min of incubation with [35S]-methionine and
kept throughout the chase. Treatment with BFA inhibited global protein secretion, whereas TANGO1 knockdown did not reveal an appreciable reduction in the
total amount of proteins secreted.Cell 136, 891–902, March 6, 2009 ª2009 Elsevier Inc. 899
Figure 7. A Model for TANGO1-Mediated Cargo Loading into COPII Carriers
TANGO1 is anchored to the ER exit site. We propose that, when secretory cargo such as collagen VII is synthesized, it binds to TANGO1’s SH3 domain, which is
accompanied by the binding of PRD to Sec23/24 subunits of COPII coats (1). During this period, the cargo is pushed into the growing COPII carrier (2). Once fully
loadedwith the cargo, the SH3 and PRD dissociate from their respective partners (3). This allows recruitment of Sec13/31 to finish the biogenesis of a cargo-filled
carrier (4).antibody was affinity purified on peptide column (Pacific Immunology, USA).
Collagen VII polyclonal antibody to NC2 domain was used for western blot
as described previously (Chen et al., 1997). Antibodies to Sec24D, APP, and
Ribophorin I were used as described previously (Fromme et al., 2007; Kim
et al., 2007a, 2007b). Antibodies to Sec31A, GM130, and Collagen VII a1
were purchased from BD Biosciences. Collagen I monoclonal antibody
(SP1.D8) was obtained from the Developmental Studies Hybridoma Bank.
Other antibodies were purchased from the following companies: ERGIC-53
(Alexis), Sec16L (KIAA0310 Bethyl), b-COP (Abcam), b-Actin (SIGMA), FLAG
M2 (SIGMA), and HA (Covance). Secondary antibodies for immunofluores-
cence microscopy were from Molecular Probes.
Immunofluorescence Microscopy
Cells grown on coverslips were fixed with cold methanol for 6 min unless
otherwise specified. Cells were blocked with phosphate-buffered saline
(PBS) containing 5% bovine serum albumin (BSA) and 0.1% Triton X-100 for
15 min. The primary antibody was incubated for 1 hr at room temperature,
and secondary antibodies conjugated with Alexa 488 or Alexa 594 were used
for detection. Images were taken with a CCD camera (photometric cool snap
HQ) mounted on a Nikon eclipse TE2000-U. Images were deconvolved with
Autoquant when specified.
TANGO1 Topology by Immunofluorescence Microscopy
HeLa cells on coverslips were washed with KHM buffer consisting of 20 mM
HEPES (pH 7.4), 110 mM potassium acetate, and 2 mM magnesium acetate
and then treated with KHM buffer containing 25 mg/ml digitonin for 5 min on
ice. Cells were washed once with KHM buffer and fixed with 4% PFA in PBS
for 10 min at room temperature. Cells were blocked with PBS containing 5%
BSA for 15 min and incubated with primary antibody for 1 hr. After washing
three times with PBS, cells were permeabilized with PBS containing 5%
BSA and 0.1% Triton X-100 for 15min. The cells were incubated with the other
primary antibody and secondary antibodies as described above.
Yeast Two-Hybrid Assay
Matchmaker yeast two-hybrid system 3 (Clontech) was used. AH109 strain
was transformed with pGBKT7 and pGADT7 vectors and plated on trypto-
phan- and leucine-deficient medium. The transformed colonies were further
plated on tryptophan-, leucine-, histidine-, and adenine-deficient plates for
interaction assay.
Mass Spectrometry Analysis
HeLa cells were extracted with extraction buffer consisting of 20 mM Tris-HCl
(pH 7.4), 100 mM NaCl, 1 mM EDTA, 1% Triton X-100, and protease inhibitors900 Cell 136, 891–902, March 6, 2009 ª2009 Elsevier Inc.and incubated for 30 min at 4C. The lysate was centrifuged at 20,000 3 g for
20 min. The supernatants were incubated with TANGO1 antibody with protein
A beads for 2 hr at 4C. As for control, TANGO1 antibody was preincubated
with more than 100-fold excess of TANGO1 peptide used for generating anti-
body for 2 hr at 4C before being added to the supernatants. The beads were
washed with TBS/0.1% Triton X-100 and eluted with TANGO1 peptide. A frac-
tion of elutedmaterials was analyzed by SDS-PAGE followed by silver staining.
The control eluate gave no detectable bands. The peptide was removed by
iodoacetamide precipitation. The eluted materials were digested with trypsin,
and the resulting peptides were analyzed by microcapillary liquid chromatog-
raphy and tandem mass spectrometry (MS). An in-house MS system consist-
ing of an HPLC and LTQ ion trap MS (Thermo Finnigan) was used. The
SEQUEST software package was used to analyze tandemmass spectra using
a mouse ORF database with no restriction on the protease used. Only tryptic
peptides identified after database searches were further manually inspected
for correct identification of the expected peptide fragments in the tandem
mass spectra.
In Vitro Binding
COS7 cells were transfected with 3X FLAG alone, TANGO1 full-length 3X
FLAG, TANGO1 lumen (amino acids 1–1210) 3X FLAG, TANGO1 cytoplasm
(amino acids 1211–1907) 3X FLAG, and TANGO1 DSH3 3X FLAG and cultured
for 48 hr. Cells were extracted with extraction buffer and incubated for 15 min
at 4C. The lysates were centrifuged at 20,000 3 g for 20 min. The superna-
tants were incubated with anti-FLAG M2 agarose beads (SIGMA) for 2 hr at
4C. The beads were washed with TBS/0.1% Triton X-100 and subsequently
incubated with culture medium from RDEB/FB/C7 cells (cultured for 48 hr in
the presence of 2 mg/ml ascorbic acid) for 2 hr at 4C. The beads were washed
with TBS/0.1% Triton X-100 and prepared for SDS-PAGE analysis.
Collagen Secretion
The 293/C7 (for collagen VII), RDEB/FB/C7 (for collagen VII and collagen I), and
Saos2 (for collagen I) cells were transfected with siRNA and cultured in the
presence (2 mg/ml ascorbic acid) or absence of ascorbic acid. At 24 hr after
siRNA transfection, cells were washed with PBS, and the mediums were
replaced and further cultured for 24–48 hr in the presence or absence of ascor-
bic acid. Themediums and cells were collected separately. Themediumswere
centrifuged briefly and boiled for 5 min with Laemmli sample buffer with or
without DTT and subjected to SDS-PAGE for analyzing the presence of colla-
gens. The mediums were also western blotted with b-actin to verify that there
was no contamination of cell debris. The cells were washed with PBS, ex-
tracted, and centrifuged at 14,000 rpm for 15 min at 4C. The supernatants
were boiled for 5 min with Laemmli sample buffer with DTT and subjected to
SDS-PAGE and western blotted with anti-collagens, TANGO1, and b-actin
antibodies. Image J (NIH, USA) was used for quantitation. The signals were
normalized by b-actin.
Metabolic Labeling
Control or TANGO1 siRNA-treated or untreated A431 cells were cultured in
a 6-well dish with DMEM without L-methionine and L-cysteine for 4 hr and
then pulsed with 50 mCi of [35S] methionine (Perkin Elmer) for 1 hr. Cells
were washed for five times with PBS and then chased with DMEM containing
10 mM L-methionine. The medium was collected at 0, 1, 2, and 3 hr. For BFA
treatment, 10 mg/ml of BFA was added to the medium for the last 10 min of
pulse and kept for whole-chase experiments. After 3 hr of chase, the cells
were washed with PBS for five times and collected. The cells were extracted
with 1ml of TBS/1%Triton X-100. Then, 20 ml of extracts weremixedwith scin-
tillation cocktail, and the radioactivity wasmeasured by scintillation counter for
normalization. Themedium collected was analyzed by SDS-PAGE followed by
autoradiography.
In Vitro Vesicle Formation Assay
The assay was essentially performed as described previously (Fromme et al.,
2007; Kim et al., 2007a, 2007b). Donor membranes were prepared from HeLa
cells by permeabilizing with digitonin. Rat liver cytosol was prepared as
described previously (Fromme et al., 2007; Kim et al., 2007a, 2007b). The
donor membranes were incubated at 30C for 1 hr in 20 mM HEPES-KOH
(pH 7.2), 250 mM Sorbitol, and 150 mM KOAc supplemented with ATP regen-
erating system (1mMATP, 40mMcreatine phosphate, and 0.2mg/ml creatine
phosphokinase), 0.3mMGTP or GTPgS, 4 mg/ml Sar1H79G, and 4.8mg/ml rat
liver cytosol. The reaction mixtures were centrifuged at 13,000 3 g for 12 min
at 4C, and the supernatants were subsequently centrifuged at 55,000 rpm for
25 min at 4C. The precipitants were resuspended and analyzed by SDS-
PAGE and western blotting.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and
six figures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(08)01630-9.
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